ABU Qualifying Exam Practice Questions - ABU Qualifying Examination (Part 1) Exam

Access More Questions

Per ARASENS, which triplet is now standard of care for de novo high-volume metastatic hormone-sensitive prostate cancer (mHSPC)?

ADT alone ADT + docetaxel ADT + abiraterone + prednisone ADT + docetaxel + darolutamide

Correct Answer:

ADT + docetaxel + darolutamide

Access more questions from this quiz

Continue to ABU Qualifying Exam Practice Questions - ABU Qualifying Examination (Part 1) Exam for more practice questions and the full quiz experience.

Access More Questions